Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort

Date
2013
Author
van Vollenhoven, Raymond F.
KALUNIAN, Kenneth C.
RUIZ-IRASTORZA, Guillermo
Inanc, Murat
Parker, Ben
Urowitz, Murray B.
Gladman, Dafna D.
Lunt, Mark
BAE, Sang-Cheol
SANCHEZ-GUERRERO, Jorge
ROMERO-DIAZ, Juanita
Gordon, Caroline
Clarke, Ann E.
Bernatsky, Sasha
GINZLER, Ellen M.
Isenberg, David A.
Rahman, Anisur
MERRILL, Joan T.
ALARCON, Graciela S.
FESSLER, Barri J.
Fortin, Paul R.
HANLY, John G.
Petri, Michelle
STEINSSON, Kristjan
Dooley, Mary-Anne
MANZI, Susan
KHAMASHTA, Munther A.
Ramsey-Goldman, Rosalind
ZOMA, Asad A.
Sturfelt, Gunnar K.
Nived, Ola
ARANOW, Cynthia
MACKAY, Meggan
RAMOS-CASALS, Manuel
WALLACE, Daniel J.
Lim, Sam
KAMEN, Diane L.
Peschken, Christine A.
Bruce, Ian N.
Metadata
Show full item record
Abstract
Background The metabolic syndrome (MetS) may contribute to increased cardiovascular risk in systemic lupus erythematosus (SLE). We aimed to examine the association of demographic factors, lupus phenotype and therapy exposure with the presence of MetS.
URI
http://hdl.handle.net/20.500.12627/30764
https://doi.org/10.1136/annrheumdis-2012-202106
Collections